サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1433657

血小板凝集デバイスの市場規模、シェア、動向分析レポート：製品タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

Platelet Aggregation Devices Market Size, Share & Trends Analysis Report By Product Type (Systems & Instruments, Consumables & Accessories), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 180 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
血小板凝集デバイスの市場規模、シェア、動向分析レポート：製品タイプ別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年
出版日: 2024年01月31日
発行: Grand View Research
ページ情報: 英文 180 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

血小板凝集デバイス市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の血小板凝集デバイス市場は、予測期間中にCAGR 5.6％を示し、2030年までに11億8,000万米ドルに達すると予測されています。

成長の背景には、心臓病や脳卒中などの慢性疾患の負担増があります。これらの疾患は世界の死因の多くを占めており、正確な診断・管理ツールが必要です。血小板の機能は血栓形成や血管の健康に極めて重要であるため、これらの状態を評価する上でこれらの機器は極めて重要です。

さらに、医療技術の進歩により、より高度で正確な血小板凝集デバイスが開発され、この分野における最先端技術への需要の高まりに応えています。例えば、2022年7月、Werfen社は心臓手術の検査結果のオンスクリーン・ビューワーであるGEMweb Liveを発売し、血小板機能モニタリングの統合により、心臓血管処置中のケア決定を支援しました。このデジタルソリューションは、心臓血管手術中の効率改善と臨床判断の指針となり、病院急性期医療現場における血小板凝集デバイスと関連診断ツールの需要を潜在的に増大させます。

医療政策と政策が好都合であれば市場の成長はさらに促進され、一方では医療専門家や一般住民の間で疾患に対する認識が高まっていることが、これらの製品に対する需要を高めています。血友病A、血友病B、von Willebrand病などの遺伝性出血性疾患の流行は、このような疾患を効果的に管理することの重要性を強調しています。さらに、これらの機器は重要な臨床評価やモニタリングをサポートする上で重要な役割を果たしており、これが市場の成長に寄与しています。

医療システムが進化を続け、正確な診断と患者モニタリングの重要性が強調されるにつれ、血小板凝集デバイスの需要は増加傾向にあります。さらに、研究開発活動の急増が血小板凝集デバイスの技術革新を促進し、現代医療における関連性を高めています。研究開発活動は、デバイスの感度、特異性、カスタマイズ性を高めることを目的としており、幅広い健康状態にわたってより正確な診断を可能にしています。

さらに、血小板凝集デバイスの市場参入企業は、効率的かつ効果的な製造能力に対する需要の高まりに対応するため、戦略的な取り組みを行っています。プレーヤーは新製品開発、臨床研究、技術革新に注力し、その地位を強化しています。例えば、2022年6月、Sysmex Americaの血液バンクモード付きXN-10自動血液学分析装置は、自動血液学分析装置では初となる残存白血球計数のFDA認可を取得しました。輸血医療や血液製剤製造における血液成分の品質向上のため、効率的で正確な細胞計数を提供します。このような取り組みが血小板凝集デバイス市場全体の成長を促進すると期待されています。

血小板凝集デバイス市場レポートハイライト

  • 消耗品・付属品セグメントは2023年に市場で最大のシェアを占め、予測期間中に最も速い成長率で成長すると予測されています。
  • 消耗品・付属品セグメントは、医療における診断・研究ニーズに牽引された試薬、検査キット、使い捨てコンポーネントの継続的な需要により、2023年に市場を独占しました。
  • この市場に参入している主要企業には、Siemens Healthcare GmbH、AggreDyne, Inc.、Chrono-Log Corporation、Werfen、Bio/Data Corporation、F. Hoffmann-La Roche Ltd、Sysmex Corporation、Haemonetics Corporation、Sienco, Inc.、Drucker Diagnosticsなどがあります。
  • 最終用途に基づき、市場は病院、診断センター、研究・学術機関に区分されます。2023年には、研究・学術機関セグメントが最大のシェアを占めました。
  • 北米は、同地域に製造施設が存在するため、同市場において強い地域的地位を確立しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場変数、動向、および範囲

  • 市場セグメンテーションと範囲
  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場動向と展望
  • 市場力学
    • 慢性疾患の有病率の増加
    • 技術の進歩
    • 研究開発の増加
  • 市場抑制要因分析
    • デバイスのコストが高い
  • 事業環境分析
    • SWOT分析：要因別（政治・法律、経済・技術）
    • ポーターのファイブフォース分析

第4章 製品タイプのビジネス分析

  • 血小板凝集デバイス市場：製品タイプの変動分析
  • システム・機器
  • 消耗品・付属品

第5章 用途のビジネス分析

  • 血小板凝集デバイス市場：用途の変動分析
  • 臨床用途
  • 研究用途

第6章 最終用途のビジネス分析

  • 血小板凝集デバイス市場：最終用途の変動分析
  • 病院
  • 診断センター
  • 研究・学術機関

第7章 地域のビジネス分析

  • 地域別の血小板凝集デバイス市場シェア、2023年および2030年
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第8章 競合情勢

  • 企業の分類
  • 戦略マッピング
    • 新製品の発売
    • パートナーシップ
    • 取得
    • コラボレーション
    • 資金調達
  • 主要企業の市場シェア分析、2022年
  • 企業ヒートマップ分析
  • 企業プロファイル
    • . AGGREDYNE, INC.
    • BIO/DATA CORPORATION
    • CHRONO-LOG CORPORATION
    • F. HOFFMANN-LA ROCHE LTD
    • HAEMONETICS CORPORATION
    • SIEMENS HEALTHCARE GMBH
    • WERFEN
    • SYSMEX CORPORATION
    • SIENCO, INC.
    • DRUCKER DIAGNOSTICS
図表

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 3 Global Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 4 Global Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 5 Global Platelet Aggregation Devices Market, by Region, 2018 - 2030 (USD Million)
  • Table 6 North America Platelet Aggregation Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 8 North America Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 9 North America Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 12 U.S. Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 13 Canada Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 14 Canada Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 15 Canada Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 16 Europe Platelet Aggregation Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 17 Europe Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 18 Europe Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 Europe Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 20 Germany Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 21 Germany Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 22 Germany Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 23 UK Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 24 UK Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 UK Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 26 France Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 27 France Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 28 France Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 29 Italy Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 30 Italy Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 31 Italy Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 32 Spain Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 33 Spain Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 34 Spain Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 35 Denmark Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 36 Denmark Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 Denmark Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 38 Sweden Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 39 Sweden Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 Sweden Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 41 Norway Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 42 Norway Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 Norway Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Platelet Aggregation Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 48 China Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 49 China Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 China Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 51 Japan Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 52 Japan Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 53 Japan Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 54 India Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 55 India Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 56 India Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 57 South Korea Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 58 South Korea Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 59 South Korea Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 60 Australia Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 61 Australia Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 Australia Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 63 Thailand Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 64 Thailand Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Thailand Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Platelet Aggregation Devices Market, by Country, 2018 - 2030 (USD Million)
  • Table 67 Latin America Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 68 Latin America Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 69 Latin America Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 70 Brazil Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 71 Brazil Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 72 Brazil Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 73 Mexico Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 74 Mexico Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Mexico Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 77 Argentina Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 Argentina Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 82 South Africa Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 83 South Africa Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 84 South Africa Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 85 Saudi Arabia Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 88 UAE Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 89 UAE Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 90 UAE Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)
  • Table 91 Kuwait Platelet Aggregation Devices Market, by Product type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Platelet Aggregation Devices Market, by Application, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Platelet Aggregation Devices Market, by End-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Platelet Aggregation Devices Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Platelet Aggregation Devices Market: Product type Movement Analysis
  • Fig. 16 Global Platelet Aggregation Devices Market, by Systems and Instruments, 2018 - 2030 (USD Million)
  • Fig. 17 Global Platelet Aggregation Devices Market, by Consumables and Accessories, 2018 - 2030 (USD Million)
  • Fig. 18 Global Platelet Aggregation Devices Market: Application Movement Analysis
  • Fig. 19 Global Platelet Aggregation Devices Market, by Clinical Applications, 2018 - 2030 (USD Million)
  • Fig. 20 Global Platelet Aggregation Devices Market, by Research Applications, 2018 - 2030 (USD Million)
  • Fig. 21 Global Platelet Aggregation Devices Market: End-use Movement Analysis
  • Fig. 22 Global Platelet Aggregation Devices Market, by Hospital, 2018 - 2030 (USD Million)
  • Fig. 23 Global Platelet Aggregation Devices Market, by Diagnostic Centers, 2018 - 2030 (USD Million)
  • Fig. 24 Global Platelet Aggregation Devices Market, by Research and Academic Institutes, 2018 - 2030 (USD Million)
  • Fig. 25 Regional Marketplace: Key Takeaways
  • Fig. 26 Regional Outlook, 2023 & 2030
  • Fig. 27 Global Platelet Aggregation Devices Market: Region Movement Analysis
  • Fig. 28 North America Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 29 U.S. Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 30 Canada Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 32 Germany Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 33 UK Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 34 France Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 35 Italy Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 36 Spain Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 37 Denmark Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 38 Sweden Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 39 Norway Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 40 Asia Pacific Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 41 Japan Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 42 China Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 43 India Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 44 Australia Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 45 South Korea Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 46 Thailand Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 47 Latin America Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 48 Brazil Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 49 Mexico Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 50 Argentina Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 51 Middle East and Africa Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • Fig. 55 Kuwait Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68040-188-5

Platelet Aggregation Devices Market Growth & Trends:

The global platelet aggregation devices market is expected to reach USD 1.18 billion by 2030 exhibiting a CAGR of 5.6% during the forecast period, according to a new report by Grand View Research, Inc. The growth is attributed to the increasing burden of chronic diseases such as heart disease and strokes. These conditions account for many global deaths, necessitating precise diagnostic and management tools. These devices are pivotal in assessing these conditions since platelet function is crucial in clot formation and blood vessel health.

Furthermore, advancements in healthcare technology have led to the development of more advanced and accurate platelet aggregation devices, meeting the growing demand for cutting-edge technology in the sector. For instance, in July 2022, Werfen launched GEMweb Live, an onscreen viewer for cardiac surgery test results, aiding in care decisions during cardiovascular procedures, with integration for platelet function monitoring. This digital solution can improve efficiency and guide clinical decisions during cardiovascular surgeries, potentially increasing the demand for platelet aggregation devices and related diagnostic tools in hospital acute care settings.

Healthcare policies and regulations further drive market growth when favorable while increasing awareness of disorders among healthcare professionals and the general population enhances the demand for these products. The prevalence of hereditary bleeding disorders such as hemophilia A, hemophilia B, and von Willebrand disease underscores the importance in managing such conditions effectively. Moreover, these devices play a crucial role in supporting critical clinical assessments and monitoring, which is contributing to the market's growth.

As healthcare systems continue to evolve and highlight the importance of accurate diagnostics and patient monitoring, the demand for platelet aggregation devices is on the rise. Additionally, the surge in R&D activities is driving innovation in platelet aggregation devices, making them increasingly relevant in modern healthcare. R&D efforts aim to enhance device sensitivity, specificity, and customization, allowing for more precise diagnostics across a wide range of health conditions.

Furthermore, platelet aggregation devices market players are undertaking strategic initiatives to address the growing demand for efficient and effective manufacturing capacity. Players are focusing on developing new products, clinical research, and innovation to strengthen their position. For instance, in June 2022, Sysmex America's XN-10 Automated Hematology Analyzer with Blood Bank mode received FDA clearance for residual white blood cell counting, a first in automated hematology analyzers. It provides efficient and accurate cell counts for blood component quality in transfusion medicine and blood product manufacturing. Such initiatives are expected to propel the overall growth of platelet aggregation devices market.

Platelet Aggregation Devices Market Report Highlights:

  • The consumables and accessories segment held the largest share in 2023 of the market and is anticipated to grow at the fastest growth rate over the forecast period
  • The consumables & accessories segment dominated the market in 2023 owing to ongoing demand for reagents, test kits, and disposable components, driven by diagnostic and research needs in healthcare
  • A few of the key players operating in the market include Siemens Healthcare GmbH, AggreDyne, Inc., Chrono-Log Corporation, Werfen, Bio/Data Corporation, F. Hoffmann-La Roche Ltd, Sysmex Corporation, Haemonetics Corporation, Sienco, Inc., and Drucker Diagnostics.
  • Based on end use, the market is segmented into hospitals, diagnostic centers, and research and academic institutes. The research and academic institutes segment held the largest share in 2023.
  • North America has established a strong regional position in the market due to the presence of manufacturing facilities in the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End-use
  • 1.3. Regional Scope
  • 1.4. Estimates and Forecasts Timeline
  • 1.5. Research Methodology
  • 1.6. Information Procurement
    • 1.6.1. Purchased database
    • 1.6.2. GVR's internal database
    • 1.6.3. Secondary sources
    • 1.6.4. Primary research
    • 1.6.5. Details of Primary Research
      • 1.6.5.1. Data for primary interviews in North America
      • 1.6.5.2. Data for primary interviews in Europe
      • 1.6.5.3. Data for primary interviews in Asia Pacific
      • 1.6.5.4. Data for primary interviews in Latin America
      • 1.6.5.5. Data for Primary interviews in MEA
  • 1.7. Information or Data Analysis
    • 1.7.1. Data analysis models
  • 1.8. Market Formulation & Validation
  • 1.9. Model Details
    • 1.9.1. Commodity flow analysis (Model 1)
    • 1.9.2. Approach 1: Commodity flow approach
    • 1.9.3. Volume price analysis (Model 2)
    • 1.9.4. Approach 2: Volume price analysis
  • 1.10. List of Secondary Sources
  • 1.11. List of Primary Sources
  • 1.12. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Increasing prevalence of chronic conditions
    • 3.4.2. Technological Advancement
    • 3.4.3. Increasing R&D
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of Devices
  • 3.6. Business Environment Analysis
    • 3.6.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.6.2. Porter's Five Forces Analysis

Chapter 4. Product Type Business Analysis

  • 4.1. Platelet Aggregation Devices Market: Product Type Movement Analysis
  • 4.2. Systems and Instruments
    • 4.2.1. Systems and Instruments Market, 2018 - 2030 (USD Million)
  • 4.3. Consumables and Accessories
    • 4.3.1. Consumables and Accessories Market, 2018 - 2030 (USD Million)

Chapter 5. Application Business Analysis

  • 5.1. Platelet Aggregation Devices Market: Site Movement Analysis
  • 5.2. Clinical Applications
    • 5.2.1. Clinical Applications Market, 2018 - 2030 (USD Million)
  • 5.3. Research Applications
    • 5.3.1. Research Applications Market, 2018 - 2030 (USD Million)

Chapter 6. End-use Business Analysis

  • 6.1. Platelet Aggregation Devices Market: End-use Movement Analysis
  • 6.2. Hospital
    • 6.2.1. Hospital Market, 2018 - 2030 (USD Million)
  • 6.3. Diagnostic Centers
    • 6.3.1. Diagnostic Centers Market, 2018 - 2030 (USD Million)
  • 6.4. Research and Academic Institutes
    • 6.4.1. Research and Academic Institutes Market, 2018 - 2030 (USD Million)

Chapter 7. Regional Business Analysis

  • 7.1. Platelet Aggregation Devices Market Share By Region, 2023 & 2030
  • 7.2. North America
    • 7.2.1. SWOT Analysis
    • 7.2.2. North America Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.2.3. U.S.
      • 7.2.3.1. Key Country Dynamics
      • 7.2.3.2. Target Disease Prevalence
      • 7.2.3.3. Competitive Scenario
      • 7.2.3.4. Regulatory Framework
      • 7.2.3.5. Reimbursement Scenario
      • 7.2.3.6. U.S. Platelet Aggregation Devices Market, 2018 - 2030 (USD MILLION)
    • 7.2.4. Canada
      • 7.2.4.1. Key Country Dynamics
      • 7.2.4.2. Target Disease Prevalence
      • 7.2.4.3. Competitive Scenario
      • 7.2.4.4. Regulatory Framework
      • 7.2.4.5. Reimbursement Scenario
      • 7.2.4.6. Canada Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. SWOT Analysis
    • 7.3.2. Europe Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Target Disease Prevalence
      • 7.3.3.3. Competitive Scenario
      • 7.3.3.4. Regulatory Framework
      • 7.3.3.5. Reimbursement Scenario
      • 7.3.3.6. Germany Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.4. UK
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Target Disease Prevalence
      • 7.3.4.3. Competitive Scenario
      • 7.3.4.4. Regulatory Framework
      • 7.3.4.5. Reimbursement Scenario
      • 7.3.4.6. UK Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.5. France
      • 7.3.5.1. Key Country Dynamics
      • 7.3.5.2. Target Disease Prevalence
      • 7.3.5.3. Competitive Scenario
      • 7.3.5.4. Regulatory Framework
      • 7.3.5.5. Reimbursement Scenario
      • 7.3.5.6. France Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Key Country Dynamics
      • 7.3.6.2. Target Disease Prevalence
      • 7.3.6.3. Competitive Scenario
      • 7.3.6.4. Regulatory Framework
      • 7.3.6.5. Reimbursement Scenario
      • 7.3.6.6. Italy Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.7. Spain
      • 7.3.7.1. Key Country Dynamics
      • 7.3.7.2. Target Disease Prevalence
      • 7.3.7.3. Competitive Scenario
      • 7.3.7.4. Regulatory Framework
      • 7.3.7.5. Reimbursement Scenario
      • 7.3.7.6. Spain Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Key Country Dynamics
      • 7.3.8.2. Target Disease Prevalence
      • 7.3.8.3. Competitive Scenario
      • 7.3.8.4. Regulatory Framework
      • 7.3.8.5. Reimbursement Scenario
      • 7.3.8.6. Denmark Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Key Country Dynamics
      • 7.3.9.2. Target Disease Prevalence
      • 7.3.9.3. Competitive Scenario
      • 7.3.9.4. Regulatory Framework
      • 7.3.9.5. Reimbursement Scenario
      • 7.3.9.6. Sweden Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.3.10. Norway
      • 7.3.10.1. Key Country Dynamics
      • 7.3.10.2. Target Disease Prevalence
      • 7.3.10.3. Competitive Scenario
      • 7.3.10.4. Regulatory Framework
      • 7.3.10.5. Reimbursement Scenario
      • 7.3.10.6. Norway Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. SWOT Analysis
    • 7.4.2. Asia Pacific Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Key Country Dynamics
      • 7.4.3.2. Target Disease Prevalence
      • 7.4.3.3. Competitive Scenario
      • 7.4.3.4. Regulatory Framework
      • 7.4.3.5. Reimbursement Scenario
      • 7.4.3.6. Japan Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Key Country Dynamics
      • 7.4.4.2. Target Disease Prevalence
      • 7.4.4.3. Competitive Scenario
      • 7.4.4.4. Regulatory Framework
      • 7.4.4.5. Reimbursement Scenario
      • 7.4.4.6. China Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Key Country Dynamics
      • 7.4.5.2. Target Disease Prevalence
      • 7.4.5.3. Competitive Scenario
      • 7.4.5.4. Regulatory Framework
      • 7.4.5.5. Reimbursement Scenario
      • 7.4.5.6. India Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. Key Country Dynamics
      • 7.4.6.2. Target Disease Prevalence
      • 7.4.6.3. Competitive Scenario
      • 7.4.6.4. Regulatory Framework
      • 7.4.6.5. Reimbursement Scenario
      • 7.4.6.6. South Korea Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.4.7. Australia
      • 7.4.7.1. Key Country Dynamics
      • 7.4.7.2. Target Disease Prevalence
      • 7.4.7.3. Competitive Scenario
      • 7.4.7.4. Regulatory Framework
      • 7.4.7.5. Reimbursement Scenario
      • 7.4.7.6. Australia Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.4.8. Thailand
      • 7.4.8.1. Key Country Dynamics
      • 7.4.8.2. Target Disease Prevalence
      • 7.4.8.3. Competitive Scenario
      • 7.4.8.4. Regulatory Framework
      • 7.4.8.5. Reimbursement Scenario
      • 7.4.8.6. Thailand Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. SWOT Analysis
    • 7.5.2. Latin America Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.5.3. Brazil
      • 7.5.3.1. Key Country Dynamics
      • 7.5.3.2. Target Disease Prevalence
      • 7.5.3.3. Competitive Scenario
      • 7.5.3.4. Regulatory Framework
      • 7.5.3.5. Reimbursement Scenario
      • 7.5.3.6. Brazil Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.5.4. Mexico
      • 7.5.4.1. Key Country Dynamics
      • 7.5.4.2. Target Disease Prevalence
      • 7.5.4.3. Competitive Scenario
      • 7.5.4.4. Regulatory Framework
      • 7.5.4.5. Reimbursement Scenario
      • 7.5.4.6. Mexico Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.5.5. Argentina
      • 7.5.5.1. Key Country Dynamics
      • 7.5.5.2. Target Disease Prevalence
      • 7.5.5.3. Competitive Scenario
      • 7.5.5.4. Regulatory Framework
      • 7.5.5.5. Reimbursement Scenario
      • 7.5.5.6. Argentina Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
  • 7.6. MEA
    • 7.6.1. SWOT Analysis
    • 7.6.2. MEA Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.6.3. South Africa
      • 7.6.3.1. Key Country Dynamics
      • 7.6.3.2. Target Disease Prevalence
      • 7.6.3.3. Competitive Scenario
      • 7.6.3.4. Regulatory Framework
      • 7.6.3.5. Reimbursement Scenario
      • 7.6.3.6. South Africa Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.6.4. Saudi Arabia
      • 7.6.4.1. Key Country Dynamics
      • 7.6.4.2. Target Disease Prevalence
      • 7.6.4.3. Competitive Scenario
      • 7.6.4.4. Regulatory Framework
      • 7.6.4.5. Reimbursement Scenario
      • 7.6.4.6. Saudi Arabia Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.6.5. UAE
      • 7.6.5.1. Key Country Dynamics
      • 7.6.5.2. Target Disease Prevalence
      • 7.6.5.3. Competitive Scenario
      • 7.6.5.4. Regulatory Framework
      • 7.6.5.5. Reimbursement Scenario
      • 7.6.5.6. UAE Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)
    • 7.6.6. Kuwait
      • 7.6.6.1. Key Country Dynamics
      • 7.6.6.2. Target Disease Prevalence
      • 7.6.6.3. Competitive Scenario
      • 7.6.6.4. Regulatory Framework
      • 7.6.6.5. Reimbursement Scenario
      • 7.6.6.6. Kuwait Platelet Aggregation Devices Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
    • 8.2.1. New Product Launch
    • 8.2.2. Partnerships
    • 8.2.3. Acquisition
    • 8.2.4. Collaboration
    • 8.2.5. Funding
  • 8.3. Key Company Market Share Analysis, 2022
  • 8.4. Company Heat Map Analysis
  • 8.5. Company Profiles
    • 8.5.1. . AGGREDYNE, INC.
      • 8.5.1.1. Company Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Strategic Initiatives
    • 8.5.2. BIO/DATA CORPORATION
      • 8.5.2.1. Company Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Strategic Initiatives
    • 8.5.3. CHRONO-LOG CORPORATION
      • 8.5.3.1. Company Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Strategic Initiatives
    • 8.5.4. F. HOFFMANN-LA ROCHE LTD
      • 8.5.4.1. Company Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Strategic Initiatives
    • 8.5.5. HAEMONETICS CORPORATION
      • 8.5.5.1. Company Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Strategic Initiatives
    • 8.5.6. SIEMENS HEALTHCARE GMBH
      • 8.5.6.1. Company Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Strategic Initiatives
    • 8.5.7. WERFEN
      • 8.5.7.1. Financial Performance
      • 8.5.7.2. Product Benchmarking
      • 8.5.7.3. Strategic Initiatives
    • 8.5.8. SYSMEX CORPORATION
      • 8.5.8.1. Company Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Strategic Initiatives
    • 8.5.9. SIENCO, INC.
      • 8.5.9.1. Financial Performance
      • 8.5.9.2. Product Benchmarking
      • 8.5.9.3. Strategic Initiatives
    • 8.5.10. DRUCKER DIAGNOSTICS
      • 8.5.10.1. Company Overview
      • 8.5.10.2. Financial Performance
      • 8.5.10.3. Product Benchmarking
      • 8.5.10.4. Strategic Initiatives